Rhythm Pharmaceuticals, Inc. (RYTM)
NASDAQ: RYTM · Real-Time Price · USD
82.25
+0.13 (0.16%)
Apr 30, 2026, 3:44 PM EDT - Market open
Rhythm Pharmaceuticals Market Cap
Rhythm Pharmaceuticals has a market cap or net worth of $5.62 billion as of April 30, 2026. Its market cap has increased by 47.71% in one year.
Market Cap
5.62B
Enterprise Value
5.31B
1-Year Change
47.71%
Ranking
Category
Stock Price
$82.25
Market Cap Chart
Since October 5, 2017, Rhythm Pharmaceuticals's market cap has increased from $813.90M to $5.62B, an increase of 590.07%. That is a compound annual growth rate of 25.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 29, 2026 | 5.61B | -21.50% |
| Dec 31, 2025 | 7.14B | 107.63% |
| Dec 31, 2024 | 3.44B | 26.64% |
| Dec 29, 2023 | 2.72B | 65.56% |
| Dec 30, 2022 | 1.64B | 227.07% |
| Dec 31, 2021 | 501.70M | -61.82% |
| Dec 31, 2020 | 1.31B | 30.30% |
| Dec 31, 2019 | 1.01B | 9.04% |
| Dec 31, 2018 | 925.00M | 16.66% |
| Dec 29, 2017 | 792.90M | -2.58% |
| Oct 5, 2017 | 813.90M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Terns Pharmaceuticals | 6.11B |
| Centessa Pharmaceuticals | 6.10B |
| Mirum Pharmaceuticals | 5.88B |
| Celcuity | 5.80B |
| CG Oncology | 5.64B |
| Immunovant | 5.56B |
| Scholar Rock Holding | 5.54B |
| PTC Therapeutics | 5.43B |